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Abstract
Plexins are cell surface receptors for the semaphorin family of cell guidance cues. The cytoplasmic region comprises a Ras
GTPase-activating protein (GAP) domain and a RhoGTPase binding domain. Concomitant binding of extracellular
semaphorin and intracellular RhoGTPase triggers GAP activity and signal transduction. The mechanism of this intricate
regulation remains elusive. We present two crystal structures of the human Plexin-B1 cytoplasmic region in complex with a
constitutively active RhoGTPase, Rac1. The structure of truncated Plexin-B1-Rac1 complex provides no mechanism for
coupling RhoGTPase and Ras binding sites. On inclusion of the juxtamembrane helix, a trimeric structure of Plexin-B1-Rac1
complexes is stabilised by a second, novel, RhoGTPase binding site adjacent to the Ras site. Site-directed mutagenesis
combined with cellular and biophysical assays demonstrate that this new binding site is essential for signalling. Our findings
are consistent with a model in which extracellular and intracellular plexin clustering events combine into a single signalling
output.
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Introduction
Plexins constitute a large family of semaphorin receptors that
mediate the repulsive chemotactic response necessary for axon
guidance in the developing nervous system. They also play an
important role in regulating cell migration, angiogenesis, and
immune responses [1,2]. Mutations in plexin receptors have been
found in cancers from a variety of tissues [3,4].
There are four classes of Plexins (A, B, C, and D) [1]. Their
architecture is conserved across the family with a large
extracellular region including the ligand binding sema domain, a
single transmembrane spanning helix, and an intracellular region
that transduces signals to a number of downstream pathways
[1,2,5]. Recently, truncated ectodomain structures of plexins from
different classes in complex with their cognate semaphorin ligands
have been solved [6–8]. They revealed a common architecture in
which two plexin monomers bind one semaphorin dimer. This
bivalency has been shown to be crucial for the function of the
plexin-semaphorin complex [6].
Plexins are transmembrane receptors distinguished by their
ability to interact directly with small GTPases of the Ras and
Rho family through their intracellular region [9,10]. They
consist of two domains, the GTPase activating protein (GAP)
domain, first identified by sequence similarity to RasGAP, and
the RhoGTPase binding domain (RBD) [11–13]. Recent
structural studies of the intracellular region of human Plexin-
B1 and mouse Plexin-A3 revealed that the GAP domain is an
integral structural unit, with the RBD forming a domain
insertion into one of the exposed GAP domain loops [14,15].
Importantly, the catalytic machinery remained identical, with
catalytic arginines found in the same positions in RasGAP and
both Plexin-B1 and Plexin-A3 [14–17].
Within the plexin family, the human Plexin-B1 signalling
pathway is the most extensively characterized to date; two
members of the Ras superfamily have been identified as targets
of the Plexin GAP activity so far, R-Ras and M-Ras [9,18].
Inactivation of R-Ras by Plexin-B1 GAP leads to suppression of
integrin activation and cell migration, ultimately leading to
repulsive axonal guidance [19,20]. Downregulation of M-Ras
leads to reduced dendritic outgrowth and branching [18]. The
Plexin-B1 RBD has been shown to bind to the Rho GTPases
Rnd1, Rac1, and RhoD exclusively in their active, GTP-bound
form [21–23]. Small GTPases of the Rho family are key players in
remodelling of the actin cytoskeleton and are involved in a
plethora of processes initiated by extracellular stimuli [24,25].
Both Rac1 and Rnd1 are important for the ligand-induced
activation of the plexin GAP activity and Rac1 has been found to
increase semaphorin binding to Plexin-B1 [19,26–28].
Simultaneous binding of semaphorin on the extracellular side
and a RhoGTPase on the intracellular side is a prerequisite for
plexin GAP activity [27,29]. Bivalent semaphorin binding can be
mimicked by extracellular, antibody-induced, clustering of the
intracellular domain and activation is observed in the presence but
not in the absence of Rnd1 [9,29]. This suggests that semaphorins
have a crucial role in bringing together plexin receptors as a step
towards activation. Despite a number of structural studies on the
plexin RBD and its complex with Rnd1 [15,30,31] it remains
unclear how RhoGTPases modulate plexins and how the
concomitant binding of ligands on the extracellular and the
intracellular side of the receptor is integrated into a single
signalling output, inactivation of Ras. To address this question we
characterized the complex between the intracellular region of
Plexin-B1 and a constitutively active form of the RhoGTPase
Rac1 both structurally and functionally.
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Structure of the Intracellular Domain of Plexin-B1 in
Complex with Constitutively Active Rac1
Several constructs of the intracellular domain of human Plexin-
B1 were designed, of which three, Plexin-B1cyto, Plexin-B1D1, and
Plexin-B1D2, could be solubly expressed in insect cells (Figure 1a).
Rac1 was rendered constitutively active by introducing a
Gln61Leu mutation [32] in addition to loading with the non-
hydrolyzable GTP analogue GppNHp. This Rac1 mutant,
expressed in E. coli, was used in all subsequent experiments and
is named Rac1* hereafter. We have determined the crystal
structure of Plexin-B1D1 in complex with Rac1* to a resolution of
3.2 A ˚ and refined it to a crystallographic R-factor of 20.7%
(Rfree=23.8%, Figure 1b, Table 1, Figure S1).
The overall structures of Plexin-B1D1 and Rac1* in the complex
are very similar to their apo-structures [15,33] with rmsd values of
1.5 A ˚ and 0.6 A ˚, respectively. However, there is some flexibility
between the Plexin-B1 GAP and the RBD with the RBD being
rotated by ,6u compared to the apo-structure (Figure S2). Rac1*
binds exclusively to the RBD and does not form any contacts with
the GAP domain. The interface between Rac1* and the Plexin-B1
RBD covers a buried surface area of 707 A ˚ 2 and is dominated by
hydrophobic interactions. Plexin-B1 residues Trp1807
Plex,
Leu1815
Plex, Thr1823
Plex, and Tyr1839
Plex form a continuous
hydrophobic patch that is complemented by Rac1 residues
Phe37
Rac, Val36
Rac, Leu67
Rac, and Leu70
Rac (Figure 1b). All of
these residues are almost completely buried within the interface (at
least 80% of the solvent accessible surface area) with the exception
of Val36
Rac (38%). Thr1823
Plex and Tyr1839
Plex are part of a
potential hydrogen bonding network involving Asp1821
Plex,
Ser1824
Plex, Asn1834
Plex, and His1838
Plex that is likely to be
crucial for the structural integrity of the domain. The hydrophobic
interaction between Plexin-B1D1 and Rac1* is extended by two
potential hydrogen bonds formed between the sidechain of
Asp38
Rac and the backbone amides of Val1811
Plex and Ala1812
Plex.
Remarkably, all of the Plexin-B1 residues described above are
conserved across A- and B-class plexins (Figure S3), therefore most
likely preserving this mode of recognition.
On Rac1*, all residues mentioned above map onto the switch I
or switch II region [11] (Figure S4) whose conformation resembles
that of active Rac1 in other Rac1-effector complexes [34]. Since
these regions undergo large conformational changes upon GTP
binding, this explains why Plexin-B1 is highly specific for active,
GTP-bound Rac1 [21]. Recently, the structure of the RBD
fragment of Plexin-B1 in complex with the constitutively active
RhoGTPase, Rnd1, has been reported [15]. Structural superpo-
sition of the RBD-RhoGTPase complexes gives an rmsd of 0.96 A ˚
(Figure S5). Despite a sequence identity of only 32% between
Rac1 and Rnd1, the Plexin-B1 RBD-Rnd1 complex interface is
very similar to the one described here. All hydrophobic
interactions as well as the two potential hydrogen bonds are
conserved in both structures.
To corroborate our structural findings we studied the affinity
between Plexin-B1cyto and Rac1*, as well as Rnd1, using surface
plasmon resonance (SPR). Rnd1 is constitutively active due to its
lack of GTPase activity [35]. Plexin-B1cyto binds to Rac1 and
Rnd1 with an affinity of 18.9 mM and 22.9 mM, respectively
(Figure 1c–e, Figure S6), which is in agreement with recently
published affinities determined by isothermal titration calorimetry
[15]. We found that a series of Plexin-B1 mutations in the
hydrophobic interface, Trp1807Glu
Plex, Leu1815Pro
Plex (previ-
ously linked to prostate cancer [4]), and Leu1815Glu
Plex,
completely abolished its interactions with Rac1* and Rnd1
(Figure 1d–e, Figure S6).
To validate these effects on binding in a functional context, we
performed COS cell-based collapse assays with the full-length
transmembrane receptor, testing for Plexin-B1 activity in vivo
[36]. Surprisingly, none of the mutants shown to abolish Rac1* or
Rnd1 binding had an effect on the collapse response of the cells
(Figure 1f–h). We explored this finding further in an independent
experimental assay to monitor directly Ras GTPase activity in
vivo. In agreement with our results from the collapse assay, none
of the interface mutants had an effect on the GAP activity of
Plexin-B1 towards R-Ras in this COS cell-based pull-down (Figure
S7). Since the necessity of RhoGTPase binding for plexin function
is well established [9,27], it was unclear how to correlate the
biophysical and cellular results.
Three-Fold Arrangement of the Plexin-B1-Rac1 Unit
The relative position of Rac1* in regard to the putative Ras
binding site revealed no mechanism for the direct regulation of
the catalytic activity of Plexin-B1 by the small RhoGTPase. To
address whether the N-terminal residues missing in the Plexin-
B1D1 construct might harbour an important site for RhoGTPase
mediated plexin activity, we solved the crystal structure of the
entire cytoplasmic domain of Plexin-B1 (Plexin-B1cyto)i n
complex with Rac1* (Figure 2a). The 4.4 A ˚ model is of high-
quality for this resolution range, reflected by the crystallographic
R-factor of 23.4% (Rfree=26.4%, Table 1, Figure S8). The
asymmetric unit contains a trimeric arrangement comprising
three copies of the Plexin-B1cyto-Rac1* unit, with each Rac1*
molecule contacting two Plexin-B1cyto molecules (Figure 2a–b).
This arrangement is not the result of crystallographic symmetry
but does show near perfect 3-fold geometry (120u between pairs
of Rac1* molecules and 117u,1 1 9 u, and 124u between the copies
of Plexin-B1cyto). Moreover, the interfaces between Plexin-B1cyto
and Rac1* are essentially identical across the three copies in the
Author Summary
Axon guidance is fundamental to the development of the
central nervous system. The growing axon is guided to its
correct location by a plethora of extracellular signals. One
of the most important extracellular signals is semaphorin,
which binds to plexin receptors on the axon. Usually, this
kind of extracellular ligand binding is sufficient to transmit
the extracellular signal to the intracellular space to trigger
changes in the cell, like axon growth. However, activation
of plexin receptors requires a ‘‘dual’’ ligand binding:
semaphorin on the extracellular side, and a RhoGTPase
on the intracellular side. Signal transduction can only occur
if both ligands are present. How this intricate regulation
mechanism is organized and how concomitant ligand
binding can be integrated into a single signalling output
within the cell has remained largely unclear. Here, we
present crystal structures of one plexin receptor, Plexin-B1,
in complex with an intracellular RhoGTPase ligand (Rac1)
and show that binding of Rac1 brings together three
Plexin-B1 molecules. In this trimeric arrangement each
plexin molecule interacts with two Rac1 ligand molecules.
This leads to a previously unidentified plexin-Rac1 ligand
interface that is crucial for its function. Further biophysical
and cellular analysis in combination with previous findings
on the extracellular plexin-semaphorin complex allow us
to propose a model for how ligand-induced clustering
events on the extra- as well as intracellular side are
combined to trigger signal transduction.
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PLoS Biology | www.plosbiology.org 2 August 2011 | Volume 9 | Issue 8 | e1001134Figure 1. Structure of the monomeric Plexin-B1D1-Rac1* complex. (a) Schematic domain organization of the Plexin-B1 receptor. ECD, extracellular
domain; TM, transmembrane region; GAP, GTPase activating protein domain; RBD, Rho GTPase binding domain. The constructs used in this study are shown
below. (b) Ribbon diagram of the complex between Plexin-B1D1and Rac1* with colour coding for Plexin-B1 as in (a) and Rac1* in wheat. GppNHp and residues
involved in the interaction are shown in stick representation. Residues mutated in SPR binding experiments are marked with an asterisk, mutations analysed in
the cell collapse assay with a blade. (c–e) Binding properties of the Plexin-B1cyto-Rac1* interaction. (c–d) Left, representative sets of experimental sensorgrams
from typical equilibrium-based binding experiments, with reference subtraction. Right, plot of the equilibrium binding response (response units [RU]) against
RhoGTPase concentrations ranging from 120 nM to 500 mM. Best-fit binding curves are shown as lines. ND, not determinable. (e) Table of binding constants
(Kd) measured by SPR between different Plexin-B1 mutants and Rac1* and Rnd1. Data are expressed as mean 6 standard error and no detectable binding is
represented by a dash. (f–h) COS-7 cell collapse assay. (f) Histogram showing the effect of different mutations on semaphorin induced collapse. Each
experiment was repeated twice and 26200 cells were counted each time. Results represent the mean with error bars showing standard error. (g–h)
Representative images of non-collapsed cells (g) and SEMA4D-induced collapsed cells (h). Scale bar, 40 mm. Arg1677Ala is a constitutively inactive Plexin-B1
m u t a n ta n ds e r v e da sn e g a t i v ec o n t r o l .
doi:10.1371/journal.pbio.1001134.g001
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symmetry generated interfaces. These observations strongly
suggest that this 3-fold complex is not purely a product of crystal
lattice formation. We were not able to show a 3-fold complex
with the soluble constructs in analytical ultracentrifugation at a
plexin concentration of 250 mM (unpublished data). This suggests
that high local concentrations in the crystal or indeed at the
plasma membrane are necessary for this arrangement and that
the 3-fold interaction might be too weak to be detected in solution
[37].
There are no major conformational changes within the three
Plexin-B1cyto-Rac1* units when compared to the one-to-one
complex. This 3-fold arrangement is mediated by a previously
unidentified second binding site for the Rho-GTPase on Plexin-
B1cyto (site B, the previously observed Plexin-B1 RBD-RhoGTPase
interface hereafter called site A). Site B involves the N-terminal
region of a-helix 11 and the loop preceding it (residues 1913
Plex–
1923
Plex) plus a-helix 16 (residues 2036
Plex–2039
Plex) and is in close
proximityto the putative Rasbindingsite (Figure 2a,c, Figure S3). It
coversa totalburiedsurfaceareaof,570 A ˚ 2,thereforesignificantly
extending the interface for Rac1 binding, and is dominated by
hydrophobic interactions. On Plexin-B1cyto the majority of contacts
(60% of buried surface area) are made by the loop residues
1913
Plex–1918
Plex (Figure 2c). Interestingly, these residues are
disordered in the apo-structures of Plexin-B1 and Plexin-A3. The
site B interface on Rac1* is predominantly formed by residues that
precede the switch I region (residues 24–33, Figure 2c). The
conformation of these residues is known not to depend on the
activation state of the RhoGTPase [11]; thus, the specificity of
Plexin-B1 for active RhoGTPases appears to result exclusively from
interactions with site A. The 3-fold complex is further stabilized by
contacts between two adjacent Plexin-B1cyto molecules, on the one
side mainly involving a loop comprising residues 1808
Plex–1813
Plex,
and on the other side a surface directly adjacent to site B (residues
1919
Plex–1938
Plex and residues 2036
Plex–2044
Plex, Figure 2c). How-
ever, this plexin-plexin interaction is unlikely to be stable without
the addition of the bridging Rac1* since it only contributes a total
buried surface area of ,310 A ˚ 2.
In order to assess the potential functional significance of site B,
we designed three Plexin-B1 mutants, Thr1920Glu
Plex, Arg1921A-
la
Plex, and Leu2036Arg
Plex. We first studied the binding affinity of
these mutants to Rac1* and Rnd1 using SPR. None of the site B
mutations had a significant effect on the affinity towards either of
the RhoGTPases, suggesting that site A alone is sufficient for
Rac1* and Rnd1 binding (Figure 3a, Figure S9). However, these
mutations as well as additional ones at these and other site B
residues (Ile1917
Plex, Leu1923
Plex, and Ala2039
Plex) completely
abolished the typical collapse response in the COS-cell assay
(Figure 3b). Every site B mutation tested was detrimental to Plexin-
B1 activity and led to a complete loss of function. All mutant
proteins showed a similar expression level, as judged by
immunofluorescence, and were present in the plasma membrane,
indicating their structural integrity (unpublished data). In the same
background, the Plexin-B1 site B mutants also did not show any
Table 1. Data collection and refinement statistics.
Data Collection and Refinement Plexin-B1D1 – Rac1* Complex PlexinB1cyto – Rac1* Complex
Data collection
Resolution (A ˚) 3.20 (3.31–3.20)
a 4.40 (4.56–4.40)
Space group C2 I212121
Cell dimension
a, b, c (A ˚) 184.1, 63.9, 84.6 142.1, 224.1, 258.3
a, b, c (u) 90, 107.5, 90 90, 90, 90
Redundancy 5.2 (5.3) 5.1 (5.2)
Completeness (%) 100 (100) 95.7 (97.5)
Rsym (%) 14.3 (65.0) 8.4 (54.4)
Avg I/s 11.3 (2.5) 15.7 (2.1)
Refinement
Resolution (A ˚) 46.0–3.2 42.0–4.4
No. Reflections 15,648 (2,807) 25,522 (2,662)
Rwork/Rfree
b (%) 20.7 (25.3)/23.8 (29.6) 23.4 (25.1)/26.4 (26.7)
Complexes in the asymmetric unit 1 3
No. Atoms
Protein 5,762 16,493
B-factors
Protein (A ˚2) 66.6 124.6
r.m.s. Deviations
Bond lengths (A ˚) 0.008 0.009
Bond angles (u) 0.93 1.16
aNumbers in parenthesis are for the highest resolution shell.
bRfree equals the Rwork against 5% of the data removed prior to refinement.
doi:10.1371/journal.pbio.1001134.t001
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the collapse assay (Figure S7). These results indicate that although
site B is not essential for binding of the RhoGTPase, it is crucial for
Plexin-B1 activity, suggesting that the 3-fold complex seen in the
crystal has functional significance. In accordance with this putative
functional role, all of the residues in site B are conserved across all
species and classes of plexins with the exception of Ala1913
Plex and
Pro1915
Plex, whose sidechains do not participate in the Rac1-site
B interaction (Figure 3c).
The Importance of the N-Terminal Segment of the Plexin-
B1 Cytoplasmic Region
The 3-fold complex revealed by the crystal structure and the cell
collapse assays suggest that GTPase binding at site B contributes to
plexin function. However, the SPR experiments reveal no direct
evidence for GTPase binding at this site. We therefore sought an
explanation for this lack of binding. In both the one-to-one and 3-
fold complex structures, we were unable to trace the N-terminal
helix (residues 1511
Plex–1562
Plex, Figure S3) due to a lack of well-
ordered electron density. Interestingly, there is a similar absence of
electron density in this region for the high resolution apo-structure
of Plexin-B1 [15]. This suggests that the N-terminal helix of
Plexin-B1 has some internal flexibility, likely around the hinge
region adjacent to Ile1563. In agreement with this, the three
residues preceding Ile1563 are Gly1562, Ser1561, and Gly1560,
which may allow large conformational freedom of the N-terminal
helix even in a trimeric arrangement. In contrast, in the apo-
structure of mouse Plexin-A3 [14], this region was well-defined.
Superposition of the Plexin-A3 structure with the 3-fold complex
reveals that this helix would block site B, therefore preventing its
interaction with Rac1* (Figure 4a). This steric hindrance model
predicts that shortening of the N-terminal helix will remove this
block and allow Rac1* and Rnd1 to bind to site B.
To test this model we generated mutant constructs lacking the
N-terminal helix (Plexin-B1D2) and assayed for RhoGTPase
binding in SPR. Indeed, RhoGTPase binding to the site A
Plexin-B1D2 mutant Leu1815Glu
Plex was now observed, suggesting
that truncation of the N-terminal helix has exposed site B
(Figure 4b, Figure S10). However, binding can only be observed
with high coupling densities of the Plexin-B1D2 on the SPR chip
(Figure 4b). This is consistent with a bivalency effect in which two
adjacent plexin molecules bind the same RhoGTPase molecule,
implying that the mutated site A is still competent to contribute to
an avidity effect [38]. At low coupling densities the Plexin-B1D2
molecules are too far apart from each other to allow a bivalent
interaction with Rac1* or Rnd1. We did not observe an increase
in affinity for wild-type N-terminal truncated Plexin-B1D2
compared to the full-length Plexin-B1cyto even at high coupling
densities (unpublished data). Binding studies on the isolated Plexin-
B1 RBD show similar affinities [21] to those we determined for the
full-length cytoplasmic region. Thus these observations suggest
that, if intact, site A dominates binding to the RhoGTPase.
Figure 2. Structure of the 3-fold Plexin-B1cyto-Rac1 complex. (a) Overview of the 3-fold arrangement of the three Plexin-B1cyto-Rac1* units.
Rac1* is coloured in wheat, orange, and yellow, and Plexin-B1cyto is coloured in skyblue, paleblue, and palecyan, respectively. GppNHp is shown as
spheres. Termini for Rac1* are labelled in the left panel, and termini for Plexin-B1cyto in the right panel. a-helices 13, 14, and 15 harbouring the
putative Ras-binding site are highlighted in red. (b) Schematic overview of the complex. The orientation and colour coding is as in (a), right panel. The
two Rac1 binding sites, site A and site B, are marked by arrowheads. (c) Detailed view of the Rac1 binding site B. The orientation of the left panel is
similar to Figure 1b, right panel. The three boxed panels correspond to the close-up views depicted in the left panel. Colour coding is as in (a).
doi:10.1371/journal.pbio.1001134.g002
Dual Binding of RhoGTPases in Plexin Signalling
PLoS Biology | www.plosbiology.org 5 August 2011 | Volume 9 | Issue 8 | e1001134Interestingly, sequence analysis of the N-terminal cytoplasmic
segment of Plexin-B1 (residues 1511–1539) predicts a trimeric
coiled-coil (Figure S11) and similar regions in other plexins from
all classes are also predicted to adopt a coiled-coil conformation.
In accordance with this, Ile1563
Plex in Plexin-B1cyto, the first
residue visible in the electron density map, points towards the
inside of the 3-fold complex locating the three N-terminal
segments in close proximity to each other (Figure 2a, right panel).
This proximity suggests an explanation for the observation of the
higher oligomeric state 3-fold complex in the crystal. Although the
N-terminal helix is not well-ordered in the structure, it could form
a trimeric coiled-coil, albeit containing significant flexibility.
Discussion
Plexin-semaphorin signalling is dependent on signals from both
the extra- and intracellular side. Several studies have shown that
both semaphorin binding on the outside and RhoGTPase binding
on the inside of the cell are required for plexin activity to occur
[9,27]. The nature of these signals and how they are integrated
into a single output, namely RasGAP activity, has been a critical
question in this field and several models have been proposed [6–
8,14,15,39].
Recently, several structures of truncated plexin ectodomains in
complex with their cognate semaphorins have been reported [6–
8]. Despite ranging across three different classes, all of these
ectodomain complexes share the same overall architecture with
one semaphorin dimer bringing together two plexin monomers. In
combination with a detailed biophysical and cellular character-
ization, these structural data have led to the proposal that the
bivalency effect is a prerequisite for plexin signalling [6,8].
For the cytoplasmic region, our structures of Plexin-B1 in
complex with Rac1* do not show major structural rearrangements
when compared to the apo-structure of Plexin-B1 [15]. For the
one-to-one complex, Rac1* is positioned distant from the Ras
binding site on the Plexin-B1D1 molecule. This excludes the
possibility of a direct interaction or regulation of RasGAP activity
Figure 3. Characterization of the second binding site. (a) Binding
constants (Kd) measured by SPR between different Plexin-B1 constructs
carrying mutations in binding site B, and Rac1* and Rnd1, respectively.
Data are expressed as mean 6 standard error. (b) Histogram showing
the effect of different site B mutations on semaphorin-induced collapse.
Results are shown as mean with error bars representing standard error
of the mean. (c) Sequence alignment of residues involved in site B
interaction. Residues that were mutated in the cell collapse assay are
marked with a triangle and those that were analysed in both SPR and
cellular assays are marked with a dot.
doi:10.1371/journal.pbio.1001134.g003
Figure 4. Analysis of the Plexin-B1cyto N-terminal juxtamem-
brane helix. (a) Superposition of mouse Plexin-A3 (PDB ID: 3IG3) onto
the 3-fold Plexin-B1cyto-Rac1* complex. Colour coding is as in Figure 2a.
Plexin-A3 is shown in pale green. The juxtamembrane helix ordered in
the Plexin-A3 structure would block Rac1* binding to site B. (b)
Representative plots of the equilibrium binding response against Rho
GTPase concentration ranging from 120 nM to 2,000 mM. ND, not
determinable. The plexin constructs used in each experiment are
schematically presented on the right with colour coding as in Figure 5.
doi:10.1371/journal.pbio.1001134.g004
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additional binding site on a neighbouring Plexin-B1cyto molecule
that is in close proximity to the predicted Ras binding site. This
interaction may result in a small conformational change in the Ras
binding region, although a detailed analysis of these changes
cannot be made due to the low resolution of our data. It is,
however, noteworthy that allosteric regulation of Ras binding by
RhoGTPase binding has been proposed by He et al. based on a
homology model of the Plexin-A3-Rnd1 complex [14]. We cannot
exclude the possibility that within the protein crystal the trimeric
arrangement is favoured over other site B mediated oligomeric
states due to the lattice contacts. Indeed, the 3-fold arrangement
constitutes the asymmetric unit in the crystal and therefore
accommodates slight variations between the three Plexin-B1-Rac1
units (see Results section).
The occurrence of a 3-fold arrangement in crystals of Plexin-B1-
Rac1 complexes appears to be dependent on the juxtamembrane,
N-terminal helix. Physiologically, this region connects the
intracellular domain with the transmembrane and extracellular
region. This suggests a mechanism by which both semaphorin
binding on the outside and RhoGTPase binding on the inside are
connected to result in RasGAP activity (Figure 5). The first step in
this model is binding of the RhoGTPase to binding site A of the
intracellular domain. Although RhoGTPase binding has been
shown to be a prerequisite for Ras binding, it is not sufficient to
trigger signalling [9]. Semaphorin binding on the outside of the
cell may result in clustering of the receptors [6] either from an
autoinhibited, monomeric, or dimeric state [14,15,39]. Such
extracellular rearrangement could be transmitted to the intracel-
lular N-terminal helix. The rearrangement of this juxtamembrane
helix would free up binding site B, allowing the RhoGTPase to
bridge two plexin molecules and stabilize the 3-fold arrangement.
Formation of a trimeric cluster could result in the proper
positioning of the catalytic machinery allowing RasGAP activity
to occur, since it has been shown that clustering of the intracellular
domain is crucial for this activity [9]. In summary, we propose that
receptor clusters nucleated by the dimeric complex on the
extracellular side and the trimeric complex on the intracellular
side will integrate both RhoGTPase and Semaphorin binding into
a single signalling output.
Materials and Methods
Protein Expression and Purification
A series of constructs of the intracellular domain of human
Plexin-B1 (GenBank ID: NP_001123554) lacking both C- and N-
terminal regions as well as the RBD were designed and cloned into
pBacPAK9 with a C-terminal His6-Tag for purification. Of these
constructs three could be solubly expressed via baculovirus
infection in Sf9 cells (Plexin-B1D1, residues 1533–2135; Plexin-
B1D2, residues 1543–2135; and Plexin-B1cyto, residues 1511–
2135). Cells were harvested at 2,0006g for 15 min, resuspended in
binding buffer (20 mM phosphate, pH, 7.4, 500 mM NaCl,
0.5 mM b-mercaptoethanol), sonicated, and then centrifuged at
46,0006g for 1 h at 4uC. The supernatant was collected and the
protein was purified by ion metal affinity chromatography
followed by size exclusion chromatography in 10 mM Hepes,
pH 7.5, 150 mM NaCl, 2 mM TCEP [40].
Mutations were generated by a two-step overlapping PCR using
Pyrobest Polymerase (Takara). Mutant plexin constructs used for
SPR studies were expressed in human HEK 293T cells essentially
as described [41]. Three days after transfection the cells were
harvested and purified following the protocol used for the wild-
type proteins. All mutant proteins had similar expression level
compared to Plexin-B1cyto as determined by SDS-PAGE.
Rac1 Gln61Leu (residues 1–176, GenBank ID: CAB53579) and
Rnd1 (residues 5–200, GenBank ID: BAB17851) were cloned into
the expression vector pET22b, expressed in E. coli BL21 Star
(Invitrogen), and purified following an established protocol
described elsewhere [40]. After purification Rac1 was incubated
with 10 mM EDTA, pH 8.0, and calf intestine alkaline phospha-
tase (NEB) to degrade any bound nucleotide. Subsequently the
protein was loaded with the non-hydrolyzable GTP analogue
Figure 5. Model for intracellular plexin signalling. We propose
that the Ras-GAP activity of Plexin-B1 is a result of a two-step signalling
process. Step one would consist of Rnd1 binding to the intracellular
Plexin-B1 RBD region. Binding of Ras molecules to this complex cannot
result in GTPase activity unless a second binding event, involving
extracellular semaphorin-mediated plexin clustering, induces formation
of the intracellular 3-fold Plexin-B1-Rnd1 complexes. Such an arrange-
ment is stabilised by the interaction of Rnd1 with a novel binding site
on a neighbouring Plexin-B1 molecule, exposed following the
displacement of a juxtamembrane helix at the N-terminal of the plexin
intracellular region. In this clustered arrangement RasGAP activity can
occur and Ras gets inactivated. The trimer on the inside, in conjunction
with semaphorin-plexin dimers on the extracellular side, may lead to
the formation of an extended signalling array. R-Ras/M-Ras (Ras) and
Rnd1 (Rnd) are depicted in their GTP-bound form. Plexin-B1cyto is
depicted in blue rectangle, with sites A and B highlighted. The mobile
juxtamembrane helix at the N-terminal of the plexin intracellular region
is indicated by a red disc. The two GTPases are shown as orange ovals
(Rnd1) and green diamonds (Ras), respectively. Semaphorin induced
dimerization of the plexin ectodomain is indicated by black lines.
doi:10.1371/journal.pbio.1001134.g005
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10 mM Hepes, pH 7.5, 150 mM NaCl, 2 mM MgCl2,2m M
TCEP.
SEMA4Decto (residues 22–677) was expressed in CHO lecR
cells as previously described [6].
The Ras binding domain of Raf-1 (residues 51–131) was fused
to GST (GST-RBD), expressed in E. coli BL21 Star (Invitrogen),
and purified following an established protocol described elsewhere
[40].
Crystallization, Data Collection, and Structure Refinement
Prior to crystallization all proteins were concentrated by
ultrafiltration to 10 mg/ml and complexes were formed by mixing
Plexin-B1 and RhoGTPase in a 1:1.2 molar ratio. Nano-litre
crystallization trials were set-up using a Cartesian Technologies
robot (100 nl protein solution plus 100 nl reservoir solution) in 96-
well Greiner plates [42], placed in a TAP Homebase storage vault
maintained at 295 K, and imaged via a Veeco visualization system
[43]. The PlexinB1cyto-Rac1* complex crystallized in 1 M Li2SO4,
0.5 M ammonium sulphate, 0.1 M citrate, pH 5.6, and Plexin-
B1D1-Rac1* complex crystallized in 20% PEG 3350, 0.2 M
KSCN, 0.1 M Bis-Tris Propane, pH 6.5.
Diffraction data were collected at 100 K with the crystals being
flash-cooled in a cryo N2 gas stream. Prior to flash-freezing,
crystals were treated with a cryo protectant solution consisting of
25% (v/v) glycerol in mother liquor. The Plexin-B1D1-Rac1*
crystals crystallized as thin needles and data were collected at the
microfocus beamline ID23-2 at the European Synchrotron
Radiation Facility, France, following a helical data collection
strategy. Plexin-B1cyto-Rac1* crystals crystallized as thin squares
and data were collected at beamline I03 at Diamond Light Source,
UK. X-ray data were processed and scaled with the HKL suite
[44]. Data collection statistics are shown in Table 1.
Both structures were solved by molecular replacement using
PHASER [45] with the structure of human Plexin-B1 (PDB ID:
3HM6 [15]) and active Rac1 (PDB ID: 1MH1 [33]) as search
model. The solution was manually adjusted using COOT [46] and
refined using autoBUSTER [47]. Refinement statistics are given in
Table 1; all data within the indicated resolution range were
included. The 4.2 A ˚ structure was refined using 3-fold NCS as
implemented in autoBUSTER [47] and tight geometric restraints
to minimize the introduction of any model bias.
Stereochemical properties were assessed by MOLPROBITY
[48]. Ramachandran statistics are as follows (favoured/disallowed
(%)): Plexin-B1cyto-Rac1* 91.7/0.2, Plexin-B1D1-Rac1* 95.5/0.2
(pre-proline residue Leu1981 is in a disallowed region in both
structures). Superpositions were calculated using SHP [49]. Buried
surface areas of protein-protein interactions were calculated using
the PISA webserver (http://www.ebi.ac.uk/msd-srv/prot_int/
pistart.html).
Surface Plasmon Resonance Binding Studies
SPR experiments were performed using a Biacore T100
machine (GE Healthcare) at 25uC in standard buffer supplement-
ed with 0.05% (v/v) Tween 20. Protein concentrations were
determined from the absorbance at 280 nm using calculated
molar extinction coefficients. All plexin constructs for surface
attachment were enzymatically biotinylated within an engineered
C-terminal tag. These proteins were then attached to surfaces on
which 5,000 RU of streptavidin were coupled via primary amines
[50] yielding a density of 500–5,000 response units (RU) of
biotinylated protein. All experiments were done in duplicates with
independently purified proteins. The signal from experimental
flow cells was corrected by subtraction of a blank and reference
signal from a mock or irrelevant protein coupled flow cell. In all
experiments analyzed, the experimental trace returned to baseline
after each injection and the data fitted to a simple 1:1 Langmuir
model of binding. Kd values were obtained by nonlinear curve
fitting of the Langmuir binding isotherm (bound=C
*max/(Kd+C),
where C is analyte concentration and max is the maximum analyte
binding) evaluated using the Biacore Evaluation software (GE
Healthcare).
Functional Cell Collapse Assay
Cellular collapse assays were performed essentially as
described [36]. Briefly, COS-7 cells were seeded on glass
coverslips and transfected with full-length human Plexin B1
carrying an N-terminal Flag-tag essentially as described [42].
Two days after transfection, cells were treated with medium
containing secreted SEMA4Decto and incubated for 30 min at
37uC. Finally, the cells were fixed and stained with anti-Flag
primary antibody (Sigma) and Alexa 488-labelled secondary
antibody (Invitrogen). Cell nuclei were counterstained with
DAPI (Invitrogen) and cells were visualized with a TE2000U
fluorescence microscope (Nikon) equipped with an Orca CCD
camera (Hamamatsu). Plexin B1-expressing cells were classified
as collapsed or non-collapsed on the basis of reduced surface
area. Each experiment was repeated twice and 26200 cells were
c o u n t e de a c ht i m e .R e s u l t sa r es h o w na sm e a nw i t he r r o rb a r s
representing standard error of the mean.
Pull-Down Assay
Pull-down assays were performed essentially as described [51].
COS-7 cells were seeded in 6-well dishes and transfected with full-
length human Plexin-B1 and its mutants, respectively, and R-Ras.
Two days after transfection, cells were treated with medium
containing secreted SEMA4Decto and incubated for 10 min at
37uC. Cells were washed twice with ice-cold phosphate-buffered
saline and then lysed with lysis buffer (50 mM Tris-HCl, pH 7.5,
200 mM NaCl, 5 mM MgCl2, 10% glycerol, 1% Non-ident P-40
substitute, 2 mM b-mercaptoethanol). Cell lysates were incubated
with GST-RBD pre-coupled to glutathione-agarose beads (GE
Healthcare) for 45 min at 4uC. After three wash steps with lysis
buffer the beads were collected in Laemmli sample buffer and
analyzed by SDS-PAGE and immunoblotting with R-Ras- and
GST-specific antibodies, respectively.
Accession codes. Atomic coordinates and structure factors of
the Plexin-B1D1-Rac1* and the Plexin-B1cyto-Rac1* complexes
have been deposited in the Protein Data Bank with accession
numbers 3SU8 and 3SUA, respectively.
Supporting Information
Figure S1 Stereoview of the electron density of the Plexin-B1D1-
Rac1* interface. The orientation is similar to Figure 1b, right
panel. The density represents a 3.2 A ˚ SigmaA-weighted 2Fobs-
Fcalc map contoured at 1.0 s.
(TIF)
Figure S2 Superposition of the Plexin-B1apo structure onto the
Plexin-B1D1-Rac1* complex. Colour coding is as in Figure 1b with
Plexin-B1apo in pale green. Coordinates for the Plexin-B1apo
structure can be found under PDB ID: 3HM6. The complexes
were aligned onto the plexin GAP domains using SHP [49]. The
orientation is similar to Figure 1b, right panel. The slight rotation
of the Plexin-B1D1 RBD in comparison to the Plexin-B1apo
structure is indicated by an arrow.
(TIF)
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from different classes and organisms. The plexin sequences were
aligned using MULTALIN (bioinfo.genotoul.fr/multalin/multa-
lin.html) and formatted with ESPRIPT (espript.ibcp.fr/ESPript/
ESPript/). Numbering corresponds to the full-length human Plexin-
B1. Secondary structure elements are shown for human Plexin-B1.
Residues that were mutated and studied in SPR as well as in the
cellular collapse assays are marked with a dot; those that were only
studied in the cellular assay are marked with a triangle.
(TIF)
Figure S4 Sequence alignment of the human RhoGTPases
Rac1, Rnd1, and RhoD. The alignment is prepared as described
in Figure S2. Numbering corresponds to human Rac1. Secondary
structure elements are shown for human Rac1. The three regions
characteristic for small GTPases and their activation state, the P-
loop, switch I, and switch II, are marked by yellow boxes.
(TIF)
Figure S5 Superposition of the Plexin-B1 RBD-Rnd1 complex
onto the Plexin-B1D1-Rac1* structure. Colour coding is as in
Figure 1b. Rnd1 is in pale green and the Plexin-B1 RBD of the
Plexin-B1 RBD-Rnd1 complex in purple. Coordinates for the
Plexin-B1 RBD-Rnd1 complex can be found under PDB ID:
2REX. The complexes were aligned onto the plexin molecules
using SHP. The orientation is similar to Figure 1b, right panel,
with Rnd1 residues labelled in pale green.
(TIF)
Figure S6 Binding of Rac1* and Rnd1 to site A mutants of Plexin-
B1. Left, representative sets of experimental sensorgrams from typical
equilibrium-based binding experiments, with reference subtraction.
Different concentrations of the respective RhoGTPase were injected
over surfaces coupled with the plexin constructs. For all injections, the
experimental tracesreached equilibrium and returned to baseline after
the injection. Right, plot of the equilibrium binding response (response
units (RU)) against RhoGTPase concentration ranging from 120 nM
to 500 mM. Within one experiment each concentration was measured
twice. All experiments were performed in duplicate. Best-fit binding
curves corresponding with a 1:1 binding model are shown as lines.
Binding constants (Kd) are given as mean with the error representing
the standard errorofthe mean. WT,wild-type;ND,not determinable.
(a) Plexin-B1cyto Leu1815Pro+Rac1*, (b) Plexin-B1cyto Leu1815-
Glu+Rac1*, (c) Plexin-B1cyto WT+Rnd1, (d) Plexin-B1cyto
Trp1815Glu+Rnd1, (e) Plexin-B1cyto Leu1815Pro+Rnd1, and (f)
Plexin-B1cyto Leu1815Glu+Rnd1.
(TIF)
Figure S7 Mutations in site B but not site A abolish Plexin-B1
RasGAP activity. COS-7 cells transfected with full-length Plexin-B1
and its mutants were stimulated with SEMA4Decto for 10 min. The
cell lysates were incubated with GST-fused Ras-binding domain of
Raf-1 and bound R-Ras and total cell lysates were detected by
immunoblotting. The results shown are representative of two
independent experiments that yielded similar results. WT, wild-
type; mock, chicken receptor protein tyrosine phosphatase s Ig1-2.
(TIF)
Figure S8 Stereoview of the electron density of the Plexin-
B1cyto-Rac1* site B interface. The orientation is similar to
Figure 2b, third panel. The density represents a 4.4 A ˚ SigmaA-
weighted 2Fobs-Fcalc map contoured at 1.0s.
(TIF)
Figure S9 Binding of Rac1* and Rnd1 to site B mutants of Plexin-
B1. Data are presented as in Figure S5. (a) Plexin-B1cyto
Thr1920Glu+Rac1*, (b) Plexin-B1cyto Leu2036Arg+Rac1*, (c) Plexin-
B1cyto Arg1921Ala+Rac1*, (d) Plexin-B1cyto Thr1920Glu+Rnd1,
(e) Plexin-B1cyto Leu2036Arg+Rnd1, and (f) Plexin-B1cyto Arg1921Ala
+Rnd1.
(TIF)
Figure S10 Binding of Rac1* and Rnd1 to Plexin-B1cyto and
Plexin-B1D2. Data are presented as in Figure S5. (a) Plexin-B1cyto
Leu1815Glu+Rac1*, 500 RU loaded on the chip, (b) Plexin-B1cyto
Leu1815Glu+Rnd1, 500 RU loaded on the chip, (c) Plexin-B1D2
Leu1815Glu+Rac1*, 500 RU loaded on the chip, (d) Plexin-B1D2
Leu1815Glu+Rnd1, 500 RU loaded on the chip, (e) Plexin-B1D2
Leu1815Glu+Rac1*, 5,000 RU loaded on the chip, and (f) Plexin-B1D2
Leu1815Glu+Rnd1, 5,000 RU loaded on the chip. Data for binding of
Ra c 1 *o rR n d1t oP l ex i n -B 1 cyto Leu1815Glu with 5,000 RU loaded on
the chip can be found in Figure S5b and S5f, respectively.
(TIF)
Figure S11 The juxtamembrane helix is predicted to form a
trimeric coiled-coil. Coiled-coil probabilities were calculated for
human Plexin-B1 using MultiCoil (http://groups.csail.mit.edu/
cb/multicoil/cgi-bin/multicoil.cgi) and plotted against residue
number. Overall probabilities are shown in dashed blue, trimeric
coiled-coil probabilities in green, and dimeric coiled-coil proba-
bilities in red. The domain organization corresponding to the
residue numbers is shown under the graph.
(TIF)
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